SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001723128-18-000013
Filing Date
2018-05-15
Accepted
2018-05-15 16:43:44
Documents
32
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atlas-03x31x2018x10q.htm 10-Q 140331
2 EXHIBIT 31.1 exhibit311.htm EX-31.1 13258
3 EXHIBIT 31.2 exhibit312.htm EX-31.2 13104
4 EXHIBIT 32.1 exhibit321.htm EX-32.1 8010
5 EXHIBIT 32.2 exhibit322.htm EX-32.2 7012
  Complete submission text file 0001723128-18-000013.txt   793485

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ipxl-20180331.xml EX-101.INS 51107
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ipxl-20180331.xsd EX-101.SCH 12590
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ipxl-20180331_cal.xml EX-101.CAL 13582
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ipxl-20180331_def.xml EX-101.DEF 32835
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ipxl-20180331_lab.xml EX-101.LAB 125889
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ipxl-20180331_pre.xml EX-101.PRE 72595
Mailing Address C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 510-240-6000
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 18837276
SIC: 2834 Pharmaceutical Preparations